ripekg:evaluation/RIPEA49DCC9BA0CF06921 |
prov:wasInformedBy |
ripekg:evidence-aggregation/RIPEA49DCC9BA0CF06921 |
ripekg:evidence-aggregation/RIPEA49DCC9BA0CF06921 |
rdf:type |
rdfs:Resource |
ripekg:evidence-aggregation/RIPEA49DCC9BA0CF06921 |
rdf:type |
owl:Thing |
ripekg:evidence-aggregation/RIPEA49DCC9BA0CF06921 |
rdf:type |
ripe:EvidenceAggregationEvidence aggregation |
ripekg:evidence-aggregation/RIPEA49DCC9BA0CF06921 |
rdf:type |
tido:Activity |
ripekg:evidence-aggregation/RIPEA49DCC9BA0CF06921 |
prov:startedAtTime |
2026-03-24T15:25:49.102111Z |
ripekg:evidence-aggregation/RIPEA49DCC9BA0CF06921 |
prov:wasAssociatedWith |
ripekg:automated-agent/inspect-ai/1.0.0INSPECT-AI 1.0.0 |
ripekg:evidence-aggregation/RIPEA49DCC9BA0CF06921 |
prov:wasAssociatedWith |
ripekg:automated-agent/inspect-ai/1.0.0INSPECT-AI |
ripekg:evidence-aggregation/RIPEA49DCC9BA0CF06921 |
tido:contributesTo |
ripekg:research-integrity-assessment/RIPEA49DCC9BA0CF06921 |
ripekg:publication-details/RIPEA49DCC9BA0CF06921Changes in the anticitrullinated peptide antibody response in relation to therapeutic outcome in early rheumatoid arthritis: results from the SWEFOT trial |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEA49DCC9BA0CF06921 |
ripekg:registry-evidence/RIPEA49DCC9BA0CF06921 |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEA49DCC9BA0CF06921 |
ripekg:retraction-notice/19710Monoclonal IgG antibodies generated from joint-derived B cells of RA patients have a strong bias toward citrullinated autoantigen recognition |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEA49DCC9BA0CF06921 |
ripekg:study-design-evidence/RIPEA49DCC9BA0CF06921 |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEA49DCC9BA0CF06921 |